首页 > 市场调查报告书 > 製药

蝨子治疗市场：按产品类型、按分销管道、按地区：规模、份额、前景、机会分析，2023-2030 年

市场调查报告书

商品编码

1349983

蝨子治疗市场：按产品类型、按分销管道、按地区：规模、份额、前景、机会分析，2023-2030 年

Lice Treatment Market, By Product Type, By Distribution Channel, By Geography (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年08月03日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格

简介目录

到 2023 年，全球蝨子治疗市场估计为 10.498 亿美元，预计在预测期内（2023-2030 年）复合年增长率为 6%。

报告范围		报告详情
基准年	2022年	2023年市场规模	美国：10.498亿美元
之前的数据	2018年至2021年	预测期	2023-2030
预测 2023-2030 年复合年增长率：	6.00%	2030年价值预测	15.834 亿美元

蝨子是寄生在人的头部和身体（包括生殖器）上的昆虫。感染人类的蝨子有三种类型：体蝨、头蝨和生殖器蝨子。蝨子是一种无翅的小昆虫，以人类血液为食。蝨子透过密切接触和共用物品在人与人之间传播。如果没有适当的治疗，这种情况可能会復发。蝨子治疗产品可透过非处方药 (OTC) 或处方购买。这些产品将有助于去除蝨子。头蝨仅靠人类血液生存生长，一旦脱离人类宿主，几小时内就会饿死。另一方面，一旦蝨子（头蝨卵）与人类宿主分离，它们通常会在一周内死亡。虽然头蝨感染确实会造成不便和不愉快，但它们通常是无害的。

市场动态

蝨子盛行率的增加、蝨子治疗产品的容易获得以及人们意识的提高是预计在预测期内有助于全球蝨子治疗市场成长的一些关键因素。2020 年 10 月，美国食品药物管理局 (FDA) 透过名为 Rx-Over-the-Counter (OTC) Switch 的流程批准了非处方或非处方 (OTC) 的头蝨治疗乳液..2012年2月，美国FDA核准0.5% Sklice（伊维菌素）洗剂作为处方药，用于治疗6个月及以上儿童的头蝨。

本研究的主要特点

本报告对全球蝨子治疗市场进行了详细分析，并介绍了以2022年为基准年的预测期（2023-2030）的市场规模和復合年增长率（CAGR）。
它还阐明了各个细分市场的潜在收入机会，并解释了该市场有吸引力的投资主张矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和批准、市场趋势、区域前景、主要参与者采取的竞争策略等的重要见解。
它根据公司亮点、产品组合、主要亮点、财务表现和策略等参数，介绍了全球蝨子治疗市场的主要参与者。
本研究涵盖的主要公司包括 Fleming Medical Ltd、ParaPRO, LLC、Prestige Consumer Healthcare Inc.、Omega Pharma（Perrigo Company plc 的子公司）、Alliance Pharma PLC、Oystershell、Johnson & Johnson Private Limited、GSK plc 和 Arbor Pharmaceuticals Inc .（Azurity Pharmaceuticals, Inc. 的子公司）。
该报告的见解将使行销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球蝨子治疗市场报告迎合了该行业的各种利益相关者，如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
利害关係人可以透过用于分析全球蝨子治疗市场的各种策略矩阵来促进他们的决策。

北美
美国
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲
欧洲
英国
德国
意大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
东盟
澳大利亚
韩国
亚太其他地区
中东
海湾合作委员会
以色列
其他中东
非洲
北非
中部非洲
南非
世界其他地区

第八章竞争格局

Fleming Medical Ltd
ParaPRO, LLC
Prestige Consumer Healthcare Inc.
Omega Pharma（A subsidiary of Perrigo Company plc）
Alliance Pharma PLC
Oystershell
Johnson & Johnson Private Limited
GSK plc
Arbor Pharmaceuticals Inc.（A subsidiary of Azurity Pharmaceuticals, Inc.）

第9章章节

调查方法
关于出版商

简介目录

Product Code: CMI4152

The global lice treatment market is estimated to be valued at US$ 1,049.8 Mn in 2023 and is expected to exhibit a CAGR of 6% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 1,049.8 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	6.00%	2030 Value Projection:	US$ 1,583.4 Mn

Lice are parasitic insects that can be found on people's heads and bodies, including the pubic area. There are three types of lice that affect humans: body lice, head lice, and pubic lice. Lice are tiny, wingless insects that feed on human blood. Lice spread from person to person through close contact and by sharing belongings. Unless treated properly, this condition can become a recurring problem. Lice treatment products are available over-the-counter (OTC) and/or with a prescription. These products help eliminate lice. Head lice survive and thrive solely on human blood, once they're separated from the human host, they starve and perish within several hours. Nits (head lice eggs), on the other hand, generally die within a week of being released from their human host. While it's true that an infestation of head lice is inconvenient and perhaps uncomfortable, it's usually harmless.

Market Dynamics

Increasing prevalence of lice infestation, easy availability of lice treatment products, and a rise in awareness among people are some major factors expected to aid in the growth of the global lice treatment market during the forecast period. In October 2020, the U.S. Food and Drug Administration (FDA) approved a lotion to treat head lice for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch. The U.S. FDA initially approved Sklice (ivermectin) lotion, 0.5% for the treatment of head lice in patients 6 months of age and older as a prescription drug in February 2012.

Key features of the study:

This report provides an in-depth analysis of the global lice treatment market and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global lice treatment market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Fleming Medical Ltd, ParaPRO, LLC, Prestige Consumer Healthcare Inc., Omega Pharma (A subsidiary of Perrigo Company plc), Alliance Pharma PLC, Oystershell, Johnson & Johnson Private Limited, GSK plc, and Arbor Pharmaceuticals Inc. (A subsidiary of Azurity Pharmaceuticals, Inc.)
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global lice treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lice treatment market.

Detailed Segmentation:

Global Lice Treatment Market, By Product Type:
- OTC Medication
- Permethrin
- Pyrethrin
- Other Product Types
- Prescription Medication
- Ivermectin
- Spinosad
- Malathion
- Other Prescription Medications
Global Lice Treatment Market, By Distribution Channel:
- Hospitals And Clinics
- Retail Pharmacies
- Other Distribution Channels
Global Lice Treatment Market, By Geography:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Fleming Medical Ltd
- ParaPRO, LLC
- Prestige Consumer Healthcare Inc.
- Omega Pharma (A subsidiary of Perrigo Company plc)
- Alliance Pharma PLC
- Oystershell
- Johnson & Johnson Private Limited
- GSK plc
- Arbor Pharmaceuticals Inc. (A subsidiary of Azurity Pharmaceuticals, Inc.)

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis

4. Global Lice Treatment Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Lice Treatment Market, By Product Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
OTC Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Permethrin
Pyrethrin
Other Product Types
Prescription Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Ivermectin
Spinosad
Malathion
Other Prescription Medications

6. Global Lice Treatment Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Other Distribution Channels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Lice Treatment Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
North Africa
Central Africa
South Africa
Rest Of The World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)

8. Competitive Landscape

Fleming Medical Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ParaPRO, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Prestige Consumer Healthcare Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Omega Pharma (A subsidiary of Perrigo Company plc)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Alliance Pharma PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Oystershell
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Johnson & Johnson Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GSK plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Arbor Pharmaceuticals Inc. (A subsidiary of Azurity Pharmaceuticals, Inc.)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

9. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/价格

蝨子治疗市场：按产品类型、按分销管道、按地区：规模、份额、前景、机会分析，2023-2030 年